Press Release February 01, 2018

Moderna Closes $500 Million Equity Financing

Goodwin advised longtime client Moderna Therapeutics in its recent $500 million equity financing round which includes support from new U.S. and international institutional investors, and existing institutional investors. New investors include a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA), BB Biotech AG, Julius Baer, Singapore-based EDBI and Sequoia Capital China. Existing investors that also participated in this round include Fidelity Management & Research Company, Pictet, Viking Global Investors, ArrowMark Partners and Alexandria Venture Investments.

The firm also represented Moderna in the closing of its $474 million financing round in September 2016.

The Goodwin team was led by partners Stuart Cable, John Mutkoski, Kingsley Taft and associates Patricia Mets, Amoli Pandya and Sarah Smith.

For additional details on the financing round, please read the press release.